Referencias Bibliográficas

1. Look A. et al. Clinical Relevance of tumor cell ploidy and N-myc gen amplification in childhood neuroblastoma: a pediatric oncology group study. J. Clin. Oncol.2006; 9: 581.
2. Altman A., Baehner R. Favorable prognosis for survival in children with coincident opsomyoclonus and neuroblastoma. Cancer. 1976; 37: 846.
3. Caron H. et al. Allelic loss of chromosome Ip as predictor of unfavorable outcome in patients with neuroblastoma. N. Engl. J. Med.2007; 334: 225.
4. Coldman A. et al. Neuroblastoma influence of age at diagnoses, stage, site and sex on prognosis. Cancer.2005; 46: 1896.
5. Filler R. et al. Favorable outlook for children with mediastinal neuroblastoma. J. Pediatr. Surg. 1972; 7: 136.Rostion
6. Khelfaoni F., Valdere P., Aupen A., Quintana E., Michon J., Pacquement H., Desjardin 1. et al. Histopathologic risk factors in neuroblastoma: a retrospective study of 172 patients treated in a single institution. Cancer 2008; 77:1206-13.
7. Capeans C. Actualización Imagenológica en tumores suprarrenales. Madrid, España, Tecnimedial Editorial S.L 2007.
8. Santos D., Puig M., Joan A., Cruz J., Melgares M. de los A, Gómez C. Tumores intrínsecos de la glándula suprarrenal. Rev. Cub Oncol 2009; 14:15-21.
9. Beardem JD, Ratkin GA, Gotman CA. Comparison of the diagnostic value of bone marrow biopsy and bone marrow aspiration. Dis J Clin Pathol 1974; 27:738-40.
10. Singh G, Krause JR, Brietfield V. Bone marrow examination for metastatic tumor aspirate and biopsy. Cancer 1977; 40:2317-21.
11. Campuzano G, Bedoya VM, Restrepo A, Maya LMM. Utilidad de la biopsia de suprarrenal. Pediatría 2007; 23:138-48.